Instant Online Delivery!
Now you can purchase and instantly download the latest editions of Davies bestselling CD-ROM mock exams—and save shipping costs in the bargain. Start studying for the registry exams today, or earn 15 hours CME credit with no delays. It's easy.
Click here.
Check out our Newsfeed!
Know the latest in ultrasound technology, upcoming national events, and news about our authors, editors, and team. Mouse over the News FYI tab in the left column.
Adult Echocardiography Exam
Exam Content Outline
The American Registry of Diagnostic Medical Sonographers publishes its exam outlines and other important information on its website (
www.ARDMS.org
). Visit the site for complete information about applying for and taking the registry examinations. The outline for each exam indicates the approximate percentage of the exam that a particular topic represents. This information is important because it indicates the relative importance of each topic and allows you to study more effectively. For example, the topic of valvular heart disease represents 15%–25% of the Adult Echocardiography exam, whereas pericardial disease represents 2%–8%.
The complete outline for the Adult Echocardiography specialty examination appears below.
I. Anatomy and Physiology (5%–10%)
A. Ventricular Wall Segments (as Recommended by the American Society of Echocardiography)
B. Nomenclature
1. Subdivisions of ventricles
a. Inflow tract
b. Outflow tract
2. Valves
3. Great vessels
C. Coronary Sinus (vs. Descending Aorta)
D. Coronary Arteries
E. Normal Pressures (in All Four Cardiac Chambers and Great Vessels)
1. Phases of cardiac cycle
a. Electrical/mechanical systole
b. Filling phases of diastole
2. Timing of events (relative to ECG)
F. Pulmonary Veins
G. Miscellaneous
II. Technique (10%–20%)
A. Use of Equipment Controls
B. Recognition of Technical Artifacts
C. Recognition of Setup Errors
D. Use of Contrast Agents
E. Provocative Maneuvers
F. Best Approach for Doppler Studies
G. Miscellaneous
H. Two-dimensional Study
I. M-mode Patterns
J. CPR
K. Transesophageal Echocardiography
III. Valvular Heart Disease (15%–25%)
A. Mitral Valve
1. Physiology/hemodynamics
2. Mitral stenosis
a. M-mode
b. Two-dimensional study
c. Doppler study
d. Effects on:
(1) Atria
(2) Ventricles
(3) Cardiac vessels
3. Mitral regurgitation
a. M-mode
b. Two-dimensional study
c. Doppler study
d. Effects on:
(1) Atria
(2) Ventricles
(3) Cardiac vessels
(4) Pulmonary veins
e. Mitral prolapse
f. Chordal rupture
g. Flail leaflet
h. Mitral annular calcification
i. Mixed mitral valve disease (MA/MR)
B. Aortic Valve
1. Physiology/hemodynamics
2. Aortic stenosis
a. M-mode
b. Two-dimensional study
c. Doppler study
d. Effects on:
(1) Atria
(2) Ventricles
(3) Cardiac vessels
e. Etiologies
(1) Congenital
(2) Rheumatic
(3) Degenerative
f. Mixed lesions (AS/AR)
g. Distinctions between aortic stenosis and sclerosis
3. Aortic regurgitation
a. M-mode
b. Two-dimensional study
c. Doppler study
d. Effects on:
(1) Atria
(2) Ventricles
(3) Cardiac vessels
e. Etiologies
(1) Congenital
(2) Rheumatic
(3) Infectious
(4) Secondary (e.g., aortic root abnormality)
(5) Flail
f. Mixed (AS/AR)
C. Tricuspid Valve
1. Physiology/hemodynamics
2. Tricuspid stenosis
a. M-mode
b. Two-dimensional study
c. Doppler study
d. Effects on:
(1) Atria
(2) Ventricles
(3) Cardiac vessels
e. Etiologies
(1) Rheumatic
f. With mixed lesions
3. Tricuspid regurgitation
a. M-mode
b. Two-dimensional Study
c. Doppler Study
d. Effects on:
(1) Atria
(2) Ventricles
(3) Cardiac vessels
e. Etiologies
(1) Rheumatic
(2) Carcinoid
(3) Tricuspid prolapse
(4) Chordal rupture
(5) Flail leaflet
D. Pulmonary Valve
1. Physiology/hemodynamics
2. Pulmonary stenosis
a. M-mode
b. Two-dimensional study
c. Doppler study
d. Effects on:
(1) Atria
(2) Ventricles
(3) Cardiac vessels
e. Etiologies
(1) Congenital
(2) Carcinoid
3. Pulmonary regurgitation
a. M-mode
b. Two-dimensional study
c. Doppler study
d. Effects on:
(1) Atria
(2) Ventricles
(3) Cardiac vessels
e. Etiologies
(1) Carcinoid
(2) Pulmonary hypertension
f. Mixed PS/PI
E. Endocarditis
1. Physiology/hemodynamics
2. Involvement of adjacent cardiac structures
3. M-mode patterns
4. Two-dimensional study
F. Prosthetic Valves
1. Mechanical
a. Types
(1) Ball-and-cage
(2) Disc in cage
(3) Tilting-disc
b. Dysfunction
(1) Stenosis
(2) Regurgitation
(3) Thrombosis
2. Tissue types (bioprostheses)
3. Means of evaluation
a. M-mode
b. Two-dimensional study
c. Doppler study
d. Other
IV. Pericardial Disease (2%–8%)
A. Constrictive
1. Physiology/hemodynamics
2. Etiologies
3. Echocardiographic manifestations
B. Effusion
1. Physiology/hemodynamics
a. Tamponade
2. Etiologies
3. Differentiation from pleural effusion
C. Tumor
1. Primary
2. Metastatic
D. Miscellaneous
1. Adhesions
2. Nonspecific thickening
3. False positives
V. Systemic & Pulmonary Hypertensive Heart Disease (1%–3%)
A. Systemic
1. Physiology/hemodynamics
2. Echocardiographic findings
B. Pulmonary
1. Physiology/hemodynamics
2. Doppler assessment
a. From tricuspid regurgitant jet
b. From pulmonary artery acceleration time
3. Image findings
VI. Cardiomyopathies (5%–15%)
A. Hypertrophic
1. With/without obstruction
2. Associated abnormalities
a. Mitral annular calcium
b. Mitral regurgitant/left atrial enlargement
c. Fibrous scarring of septum
d. Thickening of anterior mitral valve leaflet
3. Methods of evaluation
a. Provocative maneuvers
(1) Amyl nitrite
(2) Valsalva
b. M-mode
c. Two-dimensional study
d. Doppler study (specifically for localizing site of obstruction and accessing LVOT gradients)
B. Dilated
1. Etiologies
a. Idiopathic
b. Ischemic
c. Alcoholic
2. Associated findings
a. Mitral regurgitation
b. Other chamber enlargement
c. Thrombus
C. Restrictive
1. Etiologies
2. Diastolic function
VII. Ventricular Function (10%–20%)
A. Wall Motion Abnormalities
B. Associated Findings
1. Thrombi
2. Changes in appearance of involved myocardium
3. Aneurysm
4. Valve dysfunction
5. Pericardial effusion
6. Cardiomyopathy
7. Ruptured myocardium
8. Right ventricular involvement
C. Diastolic Function
D. Normal LVF
VIII. Cardiac Tumors (2%–5%)
A. Benign (e.g., Myxoma)
B. Malignant
1. Primary vs. secondary (metastatic)
C. Pericardial Involvement
D. Differentiation from Other Masses or Artifacts
E. Complications
IX. Miscellaneous (5%–10%)
A. Arrhythmias and Conduction Disturbances
1. Effect on valve motion
2. Production of wall motion abnormalities
3. Effect on Doppler flow velocity waveforms
B. Parameters of Left Ventricular Function
C. Right Side Volume Overload
D. Other
X. Congenital Heart Disease in the Adult (3%–7%)
A. Categories
1. Aortic valve
a. Bicuspid
b. Supravalvular/subvalvular stenosis
2. Pulmonic stenosis
3. Cleft mitral valve
4. Atrial septal defect
a. Types
b. Means of assessing
(1) Contrast
(2) Doppler
c. Physiology/hemodynamics
(1) Associated chamber enlargement
(2) Direction for shunt flow
5. Ventricular septal defect
a. Types
b. Means of assessing
(1) Contrast
(2) Doppler
c. Physiology/hemodynamics
(1) Associated chamber enlargement
(2) Directions for shunt flow
6. Endocardial cushion defect
7. Ebstein's anomaly
8. Patent ductus arteriosus
9. Tetralogy of Fallot
10. Status, postoperative congenital heart disease
11. Coarctation of the aorta
XI. Diseases of the Aorta (3%–7%)
A. Marfan's Syndrome
B. Miscellaneous Aortic Dilatation
C. Aortic Aneurysm
D. Aortic Dissection
E. Sinus of Valsalva Aneurysms
F. Coarctation of the Aorta
XII. Doppler (3%–7%)
A. General Information
B. Formulas for Measurement
1. Modified Bernoulli equation
2. Pressure half-time formula
3. Doppler formula
C. Color Flow Mapping
XIII. Stress Echo (0%–3%)
Return to top.
Go back to ARDMS exam list.
View Cart
View Wish List
1-877-792-0005
Join our Mailing List.
Sign up to receive the latest promotions, discounts, and news by email.
Register here.
Real People, Real Stories
Click here to see what your colleagues are saying.
Our mission is your success. Learn how we've helped your fellow colleagues and what they think of Davies.
Testimonials
Should Not Do
“There are features that should not be used. There are concepts that should not be exploited. There are problems that should not be solved. There are programs that should not be written.”
Author:
Richard Harter
Company:
Plugables
Date:
2/4/2008
Copyright © 2012 Davies Publishing Inc. All rights Reserved.
Home
|
Contact
|
Request Catalog
|
Terms
|
Trademarks & Permissions
|
Legal Notices
|
Privacy Policy
|
Guarantee
|
Site Map